Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Ann Colosia is an Associate Director in the Market Access and Outcomes Strategy group. She has more than 15 years of experience in communicating pharmaceutical drug value to payers and physicians. She has experience conducting literature reviews, including systematic literature reviews, and developing product value dossiers and Academy of Managed Care Pharmacy (AMCP) dossiers. Before joining RTI-HS, she developed science and business materials with an educational focus for sales training programs. Prior to beginning her career in health care communications, her laboratory research dealt with glucoregulatory mechanisms affected by diabetes and autoimmune mechanisms causing autoantibody development. Dr. Colosia's writing experience includes the therapeutic areas of diabetes, cancers, gastrointestinal diseases, hypercholesterolemia, cardiovascular disease, Parkinson's disease, pulmonary diseases, hematoproliferative disorders, and autoimmune diseases.
Pulmonary disease, Chronic obstructive, Adrenergic beta-agonists, Randomized controlled trials, Bronchodilators
Review Article: J Pulm Respir Med 2013, 3: 137
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals